PRAC investigates heart inflammation reports with Pfizer vaccine
The Pharma Data
MAY 7, 2021
During an early May meeting, the European Medicines Agency’s safety committee concluded two reviews of safety signals related to COVID-19 vaccines, while it continued following other vaccine-related “topics of interest.” These included reports of heart muscle inflammation after receipt of the Pfizer-BioNTech vaccine. .
52 
Let's personalize your content